Reply to B. Ulaş Kahya et al and A. Soran et al

Affiliations

¹ Seema Ahsan Khan, MPH, MD, Feinberg School of Medicine of Northwestern University, Chicago, IL; Fengmin Zhao, MD, Dana Farber Cancer Institute, Boston, MA; Lori Goldstein, MD, Fox Chase Cancer Center, Philadelphia, PA; Joseph Sparano, MD, Mount Sinai Health System, New York, NY; and George Sledge, MD, Stanford University School of Medicine, Palo Alto, CA.

Comment

Seema Ahsan Khan et al. J Clin Oncol. 2022.

. 2022 Nov 20;40(33):3899-3901.

doi: 10.1200/JCO.22.00861. Epub 2022 Jul 12.

¹ Seema Ahsan Khan, MPH, MD, Feinberg School of Medicine of Northwestern University, Chicago, IL; Fengmin Zhao, MD, Dana Farber Cancer Institute, Boston, MA; Lori Goldstein, MD, Fox Chase Cancer Center, Philadelphia, PA; Joseph Sparano, MD, Mount Sinai Health System, New York, NY; and George Sledge, MD, Stanford University School of Medicine, Palo Alto, CA.

No abstract available

Comment on

Locoregional Therapy for Intact Primary Tumor in De Novo Stage IV Breast Cancer.
Soran A, Aytac O, Ozbas S. Soran A, et al. J Clin Oncol. 2022 Nov 20;40(33):3897-3898. doi: 10.1200/JCO.22.00802. Epub 2022 Jul 12. J Clin Oncol. 2022. PMID: 35820106 No abstract available.
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108).
Ulaş Kahya B, Sütcüoğlu O, Yazıcı O, Özdemir N. Ulaş Kahya B, et al. J Clin Oncol. 2022 Nov 20;40(33):3898. doi: 10.1200/JCO.22.00404. Epub 2022 Jul 12. J Clin Oncol. 2022. PMID: 35820107 No abstract available.